Research location
Molepolole
Botswana
Advertisement
Research activity in Molepolole
BotswanaCureCurrent currently publishes aggregate city-level research activity for this location: 9 trials and 9 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Molepolole
9 linked trials · page 1 of 1Pausing Antiretroviral Treatment Under Structured EvaluationNCT06031272 · 2024-05-28 · 1 site observation
COMPLETED
Group-Based Intervention to Improve Mental Health and Adherence Among Youth Living With HIV in Low Resource SettingsNCT04024488 · 2024-04-06 · 1 site observation
TERMINATED
Long-Term Clinical, Immunologic, and Virologic Profiles of Children Who Received Early Treatment for HIVNCT05154513 · 2022-02-02 · 1 site observation
COMPLETED
More Options for Children and Adolescents (MOCHA): Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in HIV-Infected Children and AdolescentsNCT03497676 · 2019-04-03 · 1 site observation
COMPLETED
HPV Test-and-Treat-Strategy Versus Cytology-based Strategy for Prevention of CIN2+ in HIV-Infected WomenNCT01315353 · 2012-04-04 · 1 site observation
COMPLETED
Study to Improve Survival Among HIV-Exposed Infants in BotswanaNCT01229761 · 2011-05-01 · 1 site observation
COMPLETED
Observational Study of Specificity of Mycobacterium Tuberculosis Screening and Diagnostics in HIV-Infected IndividualsNCT00865826 · 2009-12-01 · 1 site observation
COMPLETED
Immediate Versus Deferred Start of Anti-HIV Therapy in HIV-Infected Adults Being Treated for TuberculosisNCT00108862 · 2006-08-01 · 1 site observation
COMPLETED
Trizivir Vs. Kaletra and Combivir for the Prevention of Mother-to-Child Transmission of HIVNCT00270296 · 2006-06-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.